190 related articles for article (PubMed ID: 19384191)
1. Curcumin analogues exhibit enhanced growth suppressive activity in human pancreatic cancer cells.
Friedman L; Lin L; Ball S; Bekaii-Saab T; Fuchs J; Li PK; Li C; Lin J
Anticancer Drugs; 2009 Jul; 20(6):444-9. PubMed ID: 19384191
[TBL] [Abstract][Full Text] [Related]
2. New curcumin analogues exhibit enhanced growth-suppressive activity and inhibit AKT and signal transducer and activator of transcription 3 phosphorylation in breast and prostate cancer cells.
Lin L; Hutzen B; Ball S; Foust E; Sobo M; Deangelis S; Pandit B; Friedman L; Li C; Li PK; Fuchs J; Lin J
Cancer Sci; 2009 Sep; 100(9):1719-27. PubMed ID: 19558577
[TBL] [Abstract][Full Text] [Related]
3. New structural analogues of curcumin exhibit potent growth suppressive activity in human colorectal carcinoma cells.
Cen L; Hutzen B; Ball S; DeAngelis S; Chen CL; Fuchs JR; Li C; Li PK; Lin J
BMC Cancer; 2009 Mar; 9():99. PubMed ID: 19331692
[TBL] [Abstract][Full Text] [Related]
4. Curcumin analogue GO-Y030 inhibits STAT3 activity and cell growth in breast and pancreatic carcinomas.
Hutzen B; Friedman L; Sobo M; Lin L; Cen L; De Angelis S; Yamakoshi H; Shibata H; Iwabuchi Y; Lin J
Int J Oncol; 2009 Oct; 35(4):867-72. PubMed ID: 19724924
[TBL] [Abstract][Full Text] [Related]
5. Preclinical In Vitro, In Vivo, and Pharmacokinetic Evaluations of FLLL12 for the Prevention and Treatment of Head and Neck Cancers.
Anisuzzaman AS; Haque A; Rahman MA; Wang D; Fuchs JR; Hurwitz S; Liu Y; Sica G; Khuri FR; Chen ZG; Shin DM; Amin AR
Cancer Prev Res (Phila); 2016 Jan; 9(1):63-73. PubMed ID: 26511491
[TBL] [Abstract][Full Text] [Related]
6. FLLL12 induces apoptosis in lung cancer cells through a p53/p73-independent but death receptor 5-dependent pathway.
Haque A; Rahman MA; Fuchs JR; Chen ZG; Khuri FR; Shin DM; Amin AR
Cancer Lett; 2015 Jul; 363(2):166-75. PubMed ID: 25917567
[TBL] [Abstract][Full Text] [Related]
7. Curcumin inhibits constitutive STAT3 phosphorylation in human pancreatic cancer cell lines and downregulation of survivin/BIRC5 gene expression.
Glienke W; Maute L; Wicht J; Bergmann L
Cancer Invest; 2010 Feb; 28(2):166-71. PubMed ID: 20121547
[TBL] [Abstract][Full Text] [Related]
8. A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells.
Lin L; Hutzen B; Li PK; Ball S; Zuo M; DeAngelis S; Foust E; Sobo M; Friedman L; Bhasin D; Cen L; Li C; Lin J
Neoplasia; 2010 Jan; 12(1):39-50. PubMed ID: 20072652
[TBL] [Abstract][Full Text] [Related]
9. Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells.
Lin L; Hutzen B; Zuo M; Ball S; Deangelis S; Foust E; Pandit B; Ihnat MA; Shenoy SS; Kulp S; Li PK; Li C; Fuchs J; Lin J
Cancer Res; 2010 Mar; 70(6):2445-54. PubMed ID: 20215512
[TBL] [Abstract][Full Text] [Related]
10. Curcumin induces apoptosis in pancreatic cancer cells through the induction of forkhead box O1 and inhibition of the PI3K/Akt pathway.
Zhao Z; Li C; Xi H; Gao Y; Xu D
Mol Med Rep; 2015 Oct; 12(4):5415-22. PubMed ID: 26166196
[TBL] [Abstract][Full Text] [Related]
11. The curcumin analogue hydrazinocurcumin exhibits potent suppressive activity on carcinogenicity of breast cancer cells via STAT3 inhibition.
Wang X; Zhang Y; Zhang X; Tian W; Feng W; Chen T
Int J Oncol; 2012 Apr; 40(4):1189-95. PubMed ID: 22179587
[TBL] [Abstract][Full Text] [Related]
12. Curcumin analogue 1,5-bis(4-hydroxy-3-((4-methylpiperazin-1-yl)methyl)phenyl)penta-1,4-dien-3-one mediates growth arrest and apoptosis by targeting the PI3K/AKT/mTOR and PKC-theta signaling pathways in human breast carcinoma cells.
Badr G; Gul HI; Yamali C; Mohamed AAM; Badr BM; Gul M; Abo Markeb A; Abo El-Maali N
Bioorg Chem; 2018 Aug; 78():46-57. PubMed ID: 29533214
[TBL] [Abstract][Full Text] [Related]
13. Curcumin potentiates antitumor activity of L-asparaginase via inhibition of the AKT signaling pathway in acute lymphoblastic leukemia.
Wang H; Geng QR; Wang L; Lu Y
Leuk Lymphoma; 2012 Jul; 53(7):1376-82. PubMed ID: 22185211
[TBL] [Abstract][Full Text] [Related]
14. Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway.
Siwak DR; Shishodia S; Aggarwal BB; Kurzrock R
Cancer; 2005 Aug; 104(4):879-90. PubMed ID: 16007726
[TBL] [Abstract][Full Text] [Related]
15. Curcumin synergistically potentiates the growth inhibitory and pro-apoptotic effects of celecoxib in pancreatic adenocarcinoma cells.
Lev-Ari S; Zinger H; Kazanov D; Yona D; Ben-Yosef R; Starr A; Figer A; Arber N
Biomed Pharmacother; 2005 Oct; 59 Suppl 2():S276-80. PubMed ID: 16507392
[TBL] [Abstract][Full Text] [Related]
16. Involvement of ROS-p38-H2AX axis in novel curcumin analogues-induced apoptosis in breast cancer cells.
Dong Y; Yin S; Song X; Huo Y; Fan L; Ye M; Hu H
Mol Carcinog; 2016 Apr; 55(4):323-34. PubMed ID: 25647442
[TBL] [Abstract][Full Text] [Related]
17. Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells.
Wang Z; Zhang Y; Banerjee S; Li Y; Sarkar FH
Cancer; 2006 Jun; 106(11):2503-13. PubMed ID: 16628653
[TBL] [Abstract][Full Text] [Related]
18. Effects of evodiamine on PI3K/Akt and MAPK/ERK signaling pathways in pancreatic cancer cells.
Hong Z; Wang Z; Zhou B; Wang J; Tong H; Liao Y; Zheng P; Jamshed MB; Zhang Q; Chen H
Int J Oncol; 2020 Mar; 56(3):783-793. PubMed ID: 31922213
[TBL] [Abstract][Full Text] [Related]
19. Curcumin attenuates hyperglycemia-driven EGF-induced invasive and migratory abilities of pancreatic cancer via suppression of the ERK and AKT pathways.
Li W; Wang Z; Xiao X; Han L; Wu Z; Ma Q; Cao L
Oncol Rep; 2019 Jan; 41(1):650-658. PubMed ID: 30542713
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, evaluation of cytotoxic properties of promising curcumin analogues and investigation of possible molecular mechanisms.
Jordan BC; Kumar B; Thilagavathi R; Yadhav A; Kumar P; Selvam C
Chem Biol Drug Des; 2018 Jan; 91(1):332-337. PubMed ID: 28649799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
